Study guide
14.1 When Minnesota Law Is Stricter Than Federal Law
Minnesota MPJE Pharmacy Jurisprudence
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 About the Minnesota MPJE 1.2 NABP Competency Areas & Weights 1.3 How to Use This Guide & Study Strategy
2 Federal Controlled Substances Foundations
2.1 CSA Schedules I–V & MN Alignment 2.2 DEA Registration, Forms 222/106/41 & Security 2.3 Federal CS Prescription Rules (CII–CV) 2.4 Inventories, Recordkeeping & Theft/Loss
3 Federal Drug Regulation, Privacy & Supply Chain
3.1 FD&C Act, Legend vs OTC, Misbranding & Adulteration 3.2 OBRA '90, Medicaid DUR & Federal Counseling Floor 3.3 HIPAA Privacy for Pharmacy 3.4 DSCSA & Drug Supply Chain Integrity
4 MN Board, Licensure & Eligibility
4.1 Minnesota Board of Pharmacy Authority & Sources of Law 4.2 Pharmacist Licensure by Exam & Score Transfer 4.3 License Transfer (Reciprocity) & Background Checks 4.4 Interns, Preceptors & 1,600-Hour Experience
5 Renewal, CE, PIC & Discipline
5.1 License Renewal & 30-Hour Biennial CE 5.2 Pharmacist-in-Charge Duties 5.3 Discipline & Unprofessional Conduct 5.4 HPSP, Impaired Practitioners & Mandatory Reporting
6 Technicians, Interns & Supervision
6.1 Technician Registration, Training & CE 6.2 Supervision Ratios (Statute 151.102 & Rule 6800.3850) 6.3 Intern Scope, Delegation & Certification of Accuracy
7 Prescription Authority & Validity
7.1 Who May Prescribe in Minnesota 7.2 Prescription Content & Validity Requirements 7.3 Controlled Substance Prescribing (Chapter 152 + Federal) 7.4 Refills, Partial Fills & Quantity Limits
8 Advanced MN Pharmacist Practice
8.1 Collaborative Practice Agreements & Medication Therapy Management 8.2 Pharmacist Prescriptive Authority (Minn. Stat. 151.37) 8.3 Immunizations & Vaccine Administration 8.4 Drug Administration & Therapy Management
9 Counseling, DUR & Patient Safety
9.1 Patient Counseling Requirements (Rule 6800.0910) 9.2 Prospective Drug Utilization Review 9.3 Returning & Reusing Drugs (Rule 6800.2700)
10 MN PMP & Opioid Public-Health Laws
10.1 Minnesota PMP Overview, Reporting & Pharmacist Use 10.2 Naloxone Access, Steve’s Law & Opioid Antagonists 10.3 Legitimate Medical Purpose & Red Flags
11 Dispensing: Transfers, Labels & Substitution
11.1 Prescription Transfers Between Pharmacies 11.2 Labeling & Packaging of Dispensed Drugs 11.3 Generic Substitution & Product Selection 11.4 Emergency Dispensing, OTC/BTC & Pseudoephedrine
12 Pharmacy Operations & Facilities
12.1 Pharmacy Permits, Classifications & Inspections 12.2 Security, Delivery & Work Conditions 12.3 Operational Recordkeeping & Inventories 12.4 Central Fill, Centralized Processing & Automation
13 Compounding & Hazardous Drugs
13.1 Sterile, Nonsterile & Hazardous Compounding 13.2 Minnesota Compounding Rules & Beyond-Use Dates
14 Test-Day Strategy & Final Review
14.1 When Minnesota Law Is Stricter Than Federal Law 14.2 Test-Day Strategy & Common Traps
14.1 When Minnesota Law Is Stricter Than Federal Law
Key Takeaways Explain This Topic AI
NABP does not split MPJE items into separate federal and state scores—when Minnesota is stricter, apply prevailing Minnesota law as the correct practice answer.
Counseling under Rule 6800.0910 requires the pharmacist to personally initiate discussion on new prescriptions, not merely meet the federal OBRA “offer-to-counsel” floor.
Technician staffing is layered: Minn. Stat. §151.102 sets a 3:1 base (the rule’s printed 2:1 no longer applies), rule function ratios are also 3:1, and a certified technician allows +1 per pharmacy—never “unlimited.”
Minnesota PMP registration is mandatory for in-state practicing pharmacists, and reporting covers Schedules II–V plus butalbital and gabapentin.
Minnesota also tightens PSE monthly sales (6 g/30 days vs federal 9 g/30 days), work hours (12 continuous hours max under Rule 6800.2160), and adds pharmacist protocol prescribing under §151.37.
Last updated: November 2026
14.1 When Minnesota Law Is Stricter Than Federal Law
Quick Answer: The NABP MPJE does not grade a separate “federal half” and “state half.” Items blend CSA/DEA, FD&C, HIPAA, DSCSA, and OBRA floors with Minnesota statutes and Rules chapter 6800 . When both apply and Minnesota is stricter , the correct answer is the prevailing Minnesota requirement . Train that reflex before you chase obscure subsection numbers.
This chapter is your final integration pass . Earlier chapters taught each rule in depth; here you learn to compare systems the way exam writers write traps: a stem that correctly states federal law next to a choice that states Minnesota’s tighter duty.
The NABP Rule You Must Internalize
NABP’s competency model is national, but each jurisdiction’s exam is scored against the law that governs that jurisdiction’s practice. For Minnesota:
Federal floors still bind Minnesota pharmacies (DEA registration, CII refill ban, Form 222, emergency oral CII seven-day cover, CIII–CIV five refills/six months, HIPAA minimum necessary, DSCSA trading-partner rules, OBRA Medicaid counseling floor, and more).
Minnesota may raise the bar with more personnel, counseling, PMP, work-condition, PSE, labeling, transfer, or practice-authority duties.
You do not get partial credit for knowing only the federal half when the vignette is a Minnesota community or hospital practice scenario.
Decision sequence on every item:
Identify the practice setting and actor (MN-licensed pharmacist, PIC, tech, intern, nonresident mail-order, etc.).
Ask: Is there a Minnesota statute or rule that addresses this duty?
If yes and it is stricter , select Minnesota.
If Minnesota is silent , apply the clear federal rule.
If the stem invents a “federal waiver that cancels Board rules,” treat that as a distractor unless a real preemption pathway is stated.
- High-Yield Comparison Tables
- Counseling: OBRA floor vs Minnesota initiation
Topic Federal floor (OBRA ’90 / Medicaid) Minnesota (stricter practice answer)
Core duty Often framed as an offer to counsel eligible Medicaid patients, with documentation of offers/refusals in many commercial outlines Rule 6800.0910 : on a new prescription, after reviewing the patient record, a pharmacist shall personally initiate discussion of matters that enhance or optimize therapy
Who initiates Offer may be described as pharmacy staff offering a chance to speak with the pharmacist Pharmacist-initiated counseling—not a technician/clerk deciding whether counseling is “needed” by asking “Do you want to talk to the pharmacist?” as a substitute for initiation
Written procedure Federal materials emphasize policies for counseling offers Every pharmacy that must counsel keeps a written patient consultation procedure for direct oral pharmacist–patient communication
Refusal / unprofessional conduct Document offer and refusal Circumventing consultation or discouraging counseling can be unprofessional conduct under Rule 6800.2250
Exam stem pattern: “The tech asks if the patient wants counseling; the patient says no; the new Rx is sold.” Under Minnesota’s initiation model, that is not automatic compliance—especially when the pharmacist never personally initiated therapy discussion.
Technician ratios: not “unlimited,” not one slogan
Layer Rule Number / concept
Base ratio §151.102 (controls over the 2:1 printed in 6800.3850 subp. 6 ) 3 technicians : 1 pharmacist on duty since July 1, 2015
Rule function exceptions 6800.3850 3:1 for IV admixture, patient-specific unit dose, prepackaging, compounding
Statutory supervision ceiling §151.102 Pharmacist may supervise up to three technicians under personal and direct supervision
Certified +1 §151.102 Pharmacy may exceed the otherwise permitted ratio by one technician if ≥1 tech in the pharmacy holds Board-recognized national certification (e.g., PTCB)
PIC petition §151.102, subd. 2 Petition to supervise more than three; deemed approved in 90 days unless denied with reasons
Federal “ratio” None as a universal DEA/FDA number Federal law does not replace Minnesota’s ratio scheme with “unlimited techs if the PIC says so”
Anti-myth for final review: “Minnesota is always 4:1” is not a safe universal answer. 4:1 can appear when statutory three plus certified +1 align, but the legal structure is statute + rule + function + certification + petition .
PMP: registration mandate + expanded reportables
Topic Federal floor Minnesota
Pharmacist account PDMP programs vary by state; federal law does not create a single national pharmacist-registration mandate identical to MN’s Every Minnesota-licensed pharmacist practicing in-state must register and maintain a PMP user account ( §152.126 )
Reportable drugs State PDMPs commonly cover controlled substances Report Schedules II–V plus butalbital-containing products and gabapentin dispensed in or into Minnesota
System State-specific Operational system AWARxE (minnesota.pmpaware.net); Board materials at mn.gov/boards/pharmacy-pmp
Clinical use Corresponding responsibility is federal Use PMP as a patient-care and diversion tool ; query when clinically indicated and when red flags make a check essential
Trap: “Only opioids reportable” or “gabapentin is never reportable” fails Minnesota items.
Pharmacist independent prescribe protocols (§151.37)
Federal law does not automatically grant every pharmacist nationwide the same protocol lanes Minnesota codifies. Under Minn. Stat. §151.37, subds. 14–17 , Minnesota pharmacists may prescribe (after Board standardized protocols, required training, counseling/fact sheets, and non-delegation of the prescribing decision ):
- Subdivision Category
- 14 Self-administered hormonal contraceptives
- 15 FDA-approved nicotine replacement medications
- 16 Opiate antagonists for acute opiate overdose
- 17 Drugs to prevent HIV acquisition (PrEP/PEP pathway under protocol)
These four protocol lanes are not unlimited legend-drug prescribing and are not the same as CPA therapy management under §151.01, subd. 27 . Separately, subd. 18 authorizes qualifying pharmacists to prescribe, administer, and dispense legend drugs and Schedule III–V controlled substances for OUD only under its individualized assessment/documentation, federal training, DEA-registration, counseling, and nondelegation conditions. On test day, do not expand §151.37 into an open formulary.
Pseudoephedrine monthly gram limits
Limit type Federal CMEA (retail scheduled listed chemical products) Minnesota §152.02, subd. 6 (meth precursor / PSE framework taught in this guide)
- Daily 3.6 g base / day Apply daily limits consistently with product base-gram math and sale controls
- 30-day 9 g base / 30 days 6 g base / 30 days (stricter monthly ceiling commonly tested for MN)
Other controls Photo ID, logbook, behind-the-counter sales practices MN Schedule V precursor framework: age 18 , ID, log retention (classically 3 years ), package/transaction limits, behind-the-counter storage
Method: Calculate as ephedrine/pseudoephedrine base , not salt form. When federal and Minnesota quantity limits both appear, the stricter monthly 6 g/30-day Minnesota figure controls lawful retail sale math on this exam.
Work conditions: 12-hour continuous maximum
Topic Federal floor Minnesota Rule 6800.2160
Continuous hours No single national “pharmacy must schedule this way” MPJE slogan Pharmacy shall not require a pharmacist, intern, or technician to work longer than 12 continuous hours per day (inclusive of required breaks)
- Meal break Employer policy varies Working longer than six continuous hours → 30-minute uninterrupted break
- Restroom Ordinary labor norms Restroom time within each four consecutive hours
- Emergency exception — Limits yield when emergency patient-risk minimization requires longer continuous work
Work-condition items often pair with ratio and break-time dispensing traps: only already-certified prescriptions may leave during a break, and counseling constraints still apply.
Other Frequent “MN Stricter / MN-Specific” Flashpoints
Use this checklist when a stem smells federal-only:
PIC duties under Rule 6800.2400 (systems ownership, not “any staff pharmacist equals PIC”).
Technician registration before any tech task ( 6800.3850 )—federal law does not create Minnesota’s registration scheme.
Emergency legend refill under §151.211, subd. 3 (generally not CS; limited quantity/frequency; prescriber notice)—do not confuse with emergency oral CII under 21 CFR 1306.11 .
Returns/reuse under Rule 6800.2700 (general prohibition with narrow institutional exceptions).
Immunization ages and MIIC duties under §151.01, subd. 27 —state-specific administration authority.
How to Use Federal Knowledge Without Getting Trapped
Federal mastery still wins points when Minnesota adopts the federal floor:
CII: no refills (federal; Minnesota does not create ordinary CII refills).
Emergency oral CII legitimacy + seven-day covering prescription.
CIII–CIV: up to 5 refills / 6 months .
DEA Forms 222 / 106 / 41 , CSOS, corresponding responsibility.
HIPAA privacy minimum necessary and breach concepts.
DSCSA authorized trading partners and suspect product response.
The skill is integration , not federal amnesia. The wrong answer is almost always the choice that is true federally but incomplete for Minnesota practice .
Final 14.1 Drill
Before the next section’s trap list, be able to state in one sentence each:
Counseling = pharmacist initiates on new Rx ( 6800.0910 ), not bare offer.
Ratios = statutory 3:1 base (rule’s printed 2:1 no longer applies) / 3:1 functions / +1 per pharmacy with a certified tech / PIC petition—not unlimited.
PMP = mandatory registration + II–V + butalbital + gabapentin .
§151.37 = protocol lanes in subds. 14–17 plus the distinct 2026 OUD-treatment authority in subd. 18—not an open formulary.
PSE = MN 6 g/30 days tighter than federal 9 g/30 days (with 3.6 g/day federal daily floor still relevant).
Hours = 12 continuous hours max required work ( 6800.2160 ).
If you can pick the Minnesota column every time those topics appear, you have converted this guide’s depth into exam points.